VOLITIONRX LTD — Director's Dealing 2021

Feb 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-02-01

Reporting Person: Hughes Terig (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-01	Warrant (Right to Buy)	$4.9	A	185000	Acquired	2027-02-01	Common Stock (185000)	Direct

Footnotes

F1: On February 1, 2021, the Reporting Person was granted a warrant to purchase up to 185,000 shares of Common Stock of the issuer at an exercise price of $4.90 per share. The warrant will vest in full twelve months from the date of grant (subject to continuous employment through such date).